A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (pIgR), CA19-9, and thrombospondin-2 (THBS2) increased the detection of pancreatic ductal adenocarcinoma (PDAC) compared with measuring CA19-9 levels alone, according to a study published in Clinical Cancer Research.
Please follow and like us:
